- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,870 | 27.06.24 22:00:05 | -1,630 | -1,24% | 129,870 | 129,890 | 131,990 | 131,500 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 82,090 | 27.06.24 21:59:42 | +4,270 | +5,49% | 82,090 | 82,200 | 78,450 | 77,820 |
